| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Roy, S Mondal, J H Kordower, K Paha. Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8(+) T cells in the nigra of hemiparkinsonian monkey. Neuroscience. vol 302. 2016-04-26. PMID:25783477. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by the loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snpc). |
2016-04-26 |
2023-08-13 |
mouse |
| Sandy Stayte, Peggy Rentsch, Kong M Li, Bryce Visse. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease. PloS one. vol 10. issue 4. 2016-04-12. PMID:25902062. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta (snpc) and a subsequent loss of dopamine (da) within the striatum. |
2016-04-12 |
2023-08-13 |
mouse |
| Justine Renaud, Seyed Fazel Nabavi, Maria Daglia, Seyed Mohammad Nabavi, Maria-Grazia Martinol. Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease? Rejuvenation research. vol 18. issue 3. 2016-03-15. PMID:25625827. |
parkinson's disease (pd) is the second most common neurodegenerative disease, and it is characterized by the loss of the neurotransmitter dopamine and neuronal degeneration in the substantia nigra pars compacta. |
2016-03-15 |
2023-08-13 |
human |
| Javad Hami, Mehran Hosseini, Sekineh Shahi, Nassim Lotfi, Abolfazl Talebi, Mohammad Afsha. Effects of L-arginine pre-treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's diseases in Balb/c mice. Iranian journal of neurology. vol 14. issue 4. 2016-02-17. PMID:26885338. |
parkinson's disease (pd) is a common neurodegenerative disease resulting from the degeneration of dopaminergic (da) neurons in the substantia nigra pars compacta (snc). |
2016-02-17 |
2023-08-13 |
mouse |
| Keisuke Kiriyama, Hirokazu Ohtaki, Natsuki Kobayashi, Norimitsu Murai, Minako Matsumoto, Shun Sasaki, Chika Sawa, Kazue Satoh, Masaji Matsunaga, Seiji Shiod. A nucleoprotein-enriched diet suppresses dopaminergic neuronal cell loss and motor deficit in mice with MPTP-induced Parkinson's disease. Journal of molecular neuroscience : MN. vol 55. issue 3. 2015-10-15. PMID:25303858. |
parkinson's disease (pd) is an obstinate progressive neurodegenerative disease and characterized by locomotor impairment and dopaminergic neuronal degeneration in the substantia nigra pars compacta (snc). |
2015-10-15 |
2023-08-13 |
mouse |
| Judith Eschbach, Karin M Danze. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models. Neuro-degenerative diseases. vol 14. issue 1. 2015-02-12. PMID:24080741. |
parkinson's disease is a common neurodegenerative disease characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta and the formation of α-synuclein aggregates found in lewy bodies throughout the brain. |
2015-02-12 |
2023-08-12 |
mouse |
| Sabrina M Heman-Ackah, Martina Hallegger, Mahendra S Rao, Matthew J A Woo. RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis. Frontiers in molecular neuroscience. vol 6. 2014-06-24. PMID:24312000. |
parkinson's disease (pd) is a debilitating neurodegenerative disease characterized primarily by the selective death of dopaminergic (da) neurons in the substantia nigra pars compacta of the midbrain. |
2014-06-24 |
2023-08-12 |
Not clear |
| Gabriela Mercado, Pamela Valdés, Claudio Het. An ERcentric view of Parkinson's disease. Trends in molecular medicine. vol 19. issue 3. 2013-09-19. PMID:23352769. |
parkinson's disease (pd) is the second most common neurodegenerative disease and is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta and the accumulation of intracellular inclusions containing α-synuclein (αsyn). |
2013-09-19 |
2023-08-12 |
human |
| Kemal Ugur Tufekci, Ralph Meuwissen, Sermin Genc, Kursad Gen. Inflammation in Parkinson's disease. Advances in protein chemistry and structural biology. vol 88. 2012-11-13. PMID:22814707. |
parkinson's disease (pd) is a common neurodegenerative disease that is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2012-11-13 |
2023-08-12 |
Not clear |
| Mercedes Unzeta, Elisenda San. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease. International review of neurobiology. vol 100. 2012-07-24. PMID:21971010. |
parkinson's disease (pd) is a neurodegenerative disease that is characterized by preferential loss of dopaminergic neurons in the substantia nigra pars compacta, leading to declining levels of dopamine in the striatum. |
2012-07-24 |
2023-08-12 |
Not clear |
| Hironori Yokoyama, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Arak. Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson's disease. Acta neurobiologiae experimentalis. vol 71. issue 2. 2011-11-03. PMID:21731080. |
pd is well known to be a chronic and progressive neurodegenerative disease produced by a selective degeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2011-11-03 |
2023-08-12 |
mouse |
| Tito Calì, Denis Ottolini, Marisa Brin. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease. BioFactors (Oxford, England). vol 37. issue 3. 2011-10-14. PMID:21674642. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta (snpc) and the presence of intracytoplasmatic inclusions known as lewy bodies, largely composed of alpha-synuclein (α-syn). |
2011-10-14 |
2023-08-12 |
Not clear |
| Yue Yong, Hanqing Ding, Zhiqin Fan, Jia Luo, Zun-Ji K. Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease. Neurochemical research. vol 36. issue 3. 2011-05-19. PMID:21203835. |
parkinson's disease (pd) is the second most common neurodegenerative disease, characterized by the pathological loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2011-05-19 |
2023-08-12 |
human |
| Jaime N Guzman, Javier Sanchez-Padilla, David Wokosin, Jyothisri Kondapalli, Ema Ilijic, Paul T Schumacker, D James Surmeie. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature. vol 468. issue 7324. 2011-01-11. PMID:21068725. |
parkinson's disease is a pervasive, ageing-related neurodegenerative disease the cardinal motor symptoms of which reflect the loss of a small group of neurons, the dopaminergic neurons in the substantia nigra pars compacta (snc). |
2011-01-11 |
2023-08-12 |
mouse |
| Ji Won Um, Eunju Im, Hyun Jung Lee, Boram Min, Lang Yoo, Jiho Yoo, Hermann Lübbert, Christine Stichel-Gunkel, Hyun-Soo Cho, Jong Bok Yoon, Kwang Chul Chun. Parkin directly modulates 26S proteasome activity. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 35. 2010-09-20. PMID:20810900. |
parkinson's disease (pd) is a common neurodegenerative disease that involves the deterioration of dopaminergic neurons in the substantia nigra pars compacta. |
2010-09-20 |
2023-08-12 |
Not clear |
| Olivier Preynat-Seauve, Pierre R Burkhard, Jean Villard, Walter Zingg, Nathalie Ginovart, Anis Feki, Michel Dubois-Dauphin, Samia A Hurst, Alex Mauron, Marisa Jaconi, Karl-Heinz Kraus. Pluripotent stem cells as new drugs? The example of Parkinson's disease. International journal of pharmaceutics. vol 381. issue 2. 2010-02-04. PMID:19782880. |
it is one of the most prevalent neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2010-02-04 |
2023-08-12 |
Not clear |
| Jin Young Shin, Hyun-Jung Park, Young Hwan Ahn, Phil Hyu Le. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Journal of neurochemistry. vol 111. issue 4. 2009-11-06. PMID:19765187. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by selective loss of dopaminergic neurons in the pars compacta of the substantia nigra. |
2009-11-06 |
2023-08-12 |
mouse |
| Daniela Moniz Arduíno, A Raquel Esteves, Sandra M Cardoso, Catarina R Oliveir. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease. Neurochemistry international. vol 55. issue 5. 2009-10-26. PMID:19375464. |
sporadic parkinson's disease (pd) is a progressive neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta. |
2009-10-26 |
2023-08-12 |
Not clear |
| Julia Fuchs, Jakob C Mueller, Peter Lichtner, Claudia Schulte, Marita Munz, Daniela Berg, Ullrich Wüllner, Thomas Illig, Manu Sharma, Thomas Gasse. The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiology of aging. vol 30. issue 5. 2009-06-22. PMID:17905480. |
parkinson's disease (pd) is a progressive neurodegenerative disease with typical motor symptoms due to the preferential loss of midbrain dopaminergic (mda) neurons in the substantia nigra pars compacta. |
2009-06-22 |
2023-08-12 |
Not clear |
| Paula Luciana Scalzo, Nilo Ikuta, Francisco Cardoso, Andrea Regner, Antônio Lúcio Teixeir. Quantitative plasma DNA analysis in Parkinson's disease. Neuroscience letters. vol 452. issue 1. 2009-06-11. PMID:19444939. |
parkinson disease (pd) is a neurodegenerative disease resulting from the loss of the dopaminergic neurons from the substantia nigra pars compacta (snpc). |
2009-06-11 |
2023-08-12 |
human |